Loading...
PainReform Ltd.
PRFX•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.38
$-0.00(-0.36%)
PainReform Ltd. (PRFX) Financial Performance & Statements
Review PainReform Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
-53.10%
↓ 53.10%
Net Income Growth
-56.12%
↓ 56.12%
Operating Cash Flow Growth
-88.97%
↓ 88.97%
Operating Margin
-143846766656477632.00%
↓ 143846766656477632.00%
Gross Margin
-78428006082749.30%
↓ 78428006082749.30%
Net Profit Margin
-143013469091848672.00%
↓ 143013469091848672.00%
ROE
-1688.91%
↓ 1688.91%
ROIC
-704.42%
↓ 704.42%
PainReform Ltd. (PRFX) Financial Statements
Explore quarterly and annual reports for PainReform Ltd. stock.
| Metric | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $4000.00 | $4000.00 | $6000.00 | $3000.00 |
| Gross Profit | -$4000.00 | -$4000.00 | -$6000.00 | -$3000.00 |
| Gross Profit Ratio | -$392.14B | $0.00 | $0.00 | |
| R&D Expenses | $6.67M | $4.74M | $2.75M | $589000.00 |
| SG&A Expenses | $680000.00 | $819000.00 | $812000.00 | $763000.00 |
| Operating Expenses | $7.34M | $5.56M | $3.56M | $1.35M |
| Total Costs & Expenses | $7.34M | $5.57M | $3.56M | $1.35M |
| Interest Income | $34000.00 | $64000.00 | $101000.00 | $115000.00 |
| Interest Expense | $4000.00 | $5000.00 | $3000.00 | $5000.00 |
| Depreciation & Amortization | $4000.00 | $4000.00 | $6000.00 | $3000.00 |
| EBITDA | -$7.34M | -$5.56M | -$3.56M | -$1.35M |
| EBITDA Ratio | -$545172.68B | $0.00 | $0.00 | |
| Operating Income | -$7.34M | -$5.57M | -$3.56M | -$1.35M |
| Operating Income Ratio | -$545564.82B | $0.00 | $0.00 | |
| Other Income/Expenses (Net) | $33000.00 | $59000.00 | -$1.32M | $1.39M |
| Income Before Tax | -$7.31M | -$5.51M | -$4.88M | $36000.00 |
| Income Before Tax Ratio | -$539780.75B | $0.00 | $0.00 | |
| Income Tax Expense | $0.00 | $0.00 | $8000.00 | -$1.39M |
| Net Income | -$7.31M | -$5.51M | -$4.89M | $36000.00 |
| Net Income Ratio | -$539780.75B | $0.00 | $0.00 | |
| EPS | -$50.78 | -$2.72 | -$3.49 | $0.03 |
| Diluted EPS | -$50.60 | -$2.72 | -$3.49 | $0.03 |
| Weighted Avg Shares Outstanding | $3.47M | $2.03M | $1.40M | $1.09M |
| Weighted Avg Shares Outstanding (Diluted) | $3.47M | $2.03M | $1.40M | $1.09M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan